CRON.US Cronos Group Inc

Healthcare Pharmaceuticals USA Stocks
3.38 USD
Close of Nov 13, 2026
2.28 3.91
Market cap
USD 1.24B
P/E
21.1x
P/B
1.17x
ROE
7.4%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is CRON.US undervalued?

Graham number
Price3.38
Graham value3.23
Premium4.6%

CRON.US trades 4.6% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Cronos Group Inc fundamental analysis

No fundamental analysis for Cronos Group Inc yet.

Cronos Group Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Cronos Group Inc

Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and tinctures under the Spinach, Lord Jones, Lit, and Peace Naturals brand names. The company is headquartered in Stayner, Canada.

Full company profile